Related Experiment Video
Updated: May 3, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
Burden and Experiences of Head Lice Infestation Among Children in Western Australia
Tina Barrow1,2,3, Stephanie Enkel1,4, Hannah Thomas1,5
1Wesfarmers Centre of Vaccines and Infectious Diseases, The Kids Research Institute, Perth, Western Australia, Australia.
Background:
Head lice is an ectoparasitic skin infection commonly seen in primary school-aged children. In remote Australia, where rates of other skin infections and downstream sequelae are endemic, the rate of head lice infestation is unknown.
Methods:
This multimethod observational study is aimed at describing the burden of head lice for remote-residing children from nine communities in the Kimberley, Western Australia. Qualitative and quantitative data collected by the See, Treat, Prevent Skin Sores and Scabies ('SToP') Trial at 10 timepoints between May 2019 and December 2022 were analysed to understand head lice rates and community perspectives.
Findings:
Across the Kimberley over the course of the study, the mean head lice prevalence was 48.4% (SD 15.3). Of children with head lice detected at any timepoint (n = 554), repeated detection occurred at a rate of 66.8% (370/554). Head lice was mentioned in 42 yarning sessions with community members and service providers. Community voice reflected repeated head lice infestation to be detrimental to the physical and psychological well-being of children. Much of the discussion focussed on prevention of secondary bacterial infections and improving the quality and maintenance of housing to provide for healthy practices to reduce the rates of head lice.
Conclusion:
In remote-residing Australian Aboriginal children, there is a high burden of head lice. Community members reflected the impact of head lice on children's well-being and focused on addressing contributing environmental factors and preventing secondary bacterial infection.
Trial Registration:
Australian New Zealand Clinical Trials Registry Number: ACTRN12618000520235.
More Related Videos
11:13Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
Published on: November 10, 2021
05:15Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport
Published on: June 21, 2024
Related Concept Videos
Vaccinations
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Sexually Transmitted Infections
Development of Human Microbiota
Development of the Oral Microbiota